ClinicalTrials.gg
Active, not recruitingNCT06556537Rural-FrailUpdated May 18, 2026

Effects of Physical Exercise on Frailty, Mental and Physical Health of Older Adults in Rural Areas.

An interventional study of Face-to-face and video-assisted training in Old Age and Frailty, sponsored by Universidad de Zaragoza. Active, not recruiting at 1 site in Spain. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by Universidad de Zaragoza · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Sep 2023, registered Jul 2024).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 132 studies in Frailty with a site in Spain — 46 open to participants now, 54 under way, none of them phase 3. Frailty · Spain.

Planned enrollment
14th of 96
240 · median 90
Started
2023
with 5 others
No phase
93 of 132
34 open now
Primary completion
2026-12
later than 31 of 53 live
Registered
76th of 132
by date

Among the 132 studies in Frailty with a site in Spain, this one is the 14th largest by planned enrollment of the 96 interventional ones that give a count, is one of 6 that started in 2023, is one of 93 with no phase, reaches primary completion later than 31 of the 53 other live ones, and was the 76th registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

46 of the 132 studies in Frailty with a site in Spain are open now. Recruiting first, the newest first:

41 more — sign in →

All 46 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 132 studies in Frailty with a site in Spain, or all of them as a file.
02

Study summary

Global aging is a significant challenge, both economically and in terms of public health. One of the main challenges is to maintain the health and functionality of older adults. Physical exercise has been suggested as one of the best non-pharmacological tools to prevent health and functionality loss. However, existing scientific literature has mainly focused on older adults from urban centers. There are no studies focused on older people in rural areas, who have particular characteristics.

The present project aims to evaluate the effects of a face-to-face and video-assisted intervention, which incorporates multi-component physical exercise with different motivational strategies, on the mental health, physical function, and frailty of individuals over 65 years of age residing in rural areas. Additionally, it aims to determine the effectiveness, safety, and adherence of new technologies in carrying out an intervention that includes multi-component physical exercise, cognitive work, and motivational strategies through video assistance for older women and men living in rural areas.

A randomized controlled trial will be conducted, involving 240 people over the age of 65 who will be randomly divided into two groups. One group, the intervention group, will participate in a face-to-face multicomponent physical exercise program three times a week for 60 minutes per session over 12 weeks. After that, the intervention will continue through video-assisted sessions for the remaining nine months, divided into three blocks of two months of rest and one video-assisted intervention. The control group will continue with their usual daily activities but receive recommendations for physical activity and mental and physical health talks. Both groups will undergo a battery of tests to evaluate the effects of the interventions. The primary variable measured will be functional capacity, assessed through the Short Physical Performance Battery. Secondary variables will include health-related physical condition (Power frail app), cognitive function (Trail making test), and quality of life, among others.

The results expected from this study will be of significant scientific and technical importance in the field of psycho-socio-health. Consequently, the project is of utmost importance, not only to enhance the health of the rural population but also to promote individual and social sustainability.

03

Conditions studied

  • Old Age
  • Frailty

Keywords

  • Exercise
  • Rural areas
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age equal to or greater than 65 years.
  • Be able to provide voluntarily.
  • Walk autonomously.
  • Have a score of 4 points or more on the Short Physical Performance Battery (SPPB).

Exclusion criteria

Exclusion Criteria:

Those that have to do with for performing physical exercise:

  • Recent acute myocardial infarction within the last 3-6 months or unstable angina.
  • Uncontrolled atrial or ventricular arrhythmias.
  • Dissecting aortic aneurysm.
  • Severe aortic stenosis.
  • Acute endocarditis or pericarditis.
  • Uncontrolled arterial hypertension (>180/100 mmHg).
  • Acute thromboembolic disease.
  • Acute and severe heart or respiratory failure.
  • Recent bone fracture, orthostatic hypotension.
  • Diabetes or uncontrolled hypoglycemia.
  • Any pathology that causes a significant functional limitation such as advanced Parkinson's, considerable vision or hearing problems Cancer, or disease.
  • People scoring less than 4 on the SPPB (dependents).
  • Any pathology or circumstance that the primary care team considers counterproductive to participation in physical exercise.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
240 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Participants will undergo a face-to-face and video-assisted physical exercise intervention.

    Device: Face-to-face and video-assisted training

  • No intervention
    Control group

    Participants in the control group will maintain their usual lifestyle throughout the project. They will receive physical activity recommendations for older people and will attend monthly health promotion meetings.

Interventions

  • DeviceFace-to-face and video-assisted training

    During the first phase, the intervention group will receive face-to-face training over 12 weeks. Each session will last 60 minutes, and there will be five sessions per week, with three supervised and two unsupervised. In the second phase, there will be 60 work sessions, divided into blocks of four weeks on three occasions, with one month of exercise and two months of non-exercise over the remaining 9 months. This phase will be conducted via video assistance. Each session will include a warm-up of 10-15 minutes, a main part of 20-40 minutes, and a cool-down of 10-15 minutes.

    Also known as: Exercise

06

What researchers measure

Primary outcomes

  1. Frailty status.

    Frailty status measured with the Short Physical Performance Battery (SPPB). The minimum value is 0 and the maximum value is 12 points. A score of \< 10 points means frailty. Therefore, a higher score means a better outcome.

    Time frame: T0 = pre-intervention, T1 = 3 months, T2 = 6 months, T3 = 9 months, and T4 = 12 months.

Secondary outcomes

  1. Frailty.

    Frailty status measured with the Frailty Trait Scale (FTS). The minimum value for the 5-item FTS is 0 and the maximum value is 50 points. Frail participants are those with FTS5 scores \> 25 points. Therefore, a higher score means a worse outcome.

    Time frame: T0 = pre-intervention, T1 = 3 months, T2 = 6 months, T3 = 9 months, and T4 = 12 months.

  2. Power Frail App.

    App designed to assess muscle power and frailty in older adults.

    Time frame: T0 = pre-intervention, T1 = 3 months, T2 = 6 months, T3 = 9 months, and T4 = 12 months.

  3. Cognitive impairment.

    Cognitive impairment measured with the Mini Mental State Examination (MMSE) test. The minimum value is 0 and the maximum value is 30 points. Any score of 24 or more indicates a normal cognition. Therefore, higher scores indicate a worse outcome.

    Time frame: T0 = pre-intervention, T1 = 3 months, T2 = 6 months, T3 = 9 months, and T4 = 12 months.

  4. Mental health and depression.

    Mental health and depression measured with the Geriatric Depression Scale. The minimum value is 0 and the maximum value is 15 points. A score of \> 5 suggests depression. Therefore, higher scores mean a worse outcome.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months

  5. Quality of life of participants EuroQol-5D.

    Quality of life measured with the EuroQol-5D. The minimum value is 0 and the maximum value is 1. A higher score means a better outcome.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months

  6. Trail Making Test (TMT).

    Speed for attention, sequencing, mental flexibility visual search and motor function measured with the TMT parts A \& B. There is no maximum value or minimum value. In the part A, a score of \> 78 seconds suggests deficiency. In the part B is \> 273 seconds. Results for both are reported as the number of seconds required to complete the task; therefore, higher scores reveal greater impairment.

    Time frame: T0 = pre-intervention, T1 = 3 months, T2 = 6 months, T3 = 9 months, and T4 = 12 months.

  7. DeJong Gierveld Loneliness Scale.

    Emotional and social loneliness measured with the DeJong Gierveld Loneliness Scale. The minimum value is 0 and the maximum value is 6 points. This gives a possible range of scores from 0 to 6, which can be read as follows: 0 = (Least lonely) and 6 = (Most lonely). Therefore, higher scores mean a worse outcome.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months.

  8. The Aging Self-Efficacy Scale.

    The perceived level of control that elderly individuals have over the aspects, content, and outcomes of aging measured with the Aging Self-Efficacy Scale. The minimum value is 10 and the maximum value is 40 points. A higher score means a better outcome.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months.

  9. Muscular strength of the upper limbs.

    Measured with a handgrip dynamometer.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months.

  10. Muscular strength of the lower limbs.

    Measured with the stand and sit chair test.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months.

  11. Aerobic capacity.

    Six minute walk test.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months.

  12. Walking speed.

    Walking speed measured over 3, 4, and 6 meters.

    Time frame: T0 = pre-intervention, T1 = 3 months, T2 = 6 months, T3 = 9 months, and T4 = 12 months.

  13. SARC-F Questionnaire.

    Sarcopenia measured with the SARC-F questionnaire. The minimum value is 0 and the maximum value is 10 points. A score of 4 points or more indicates a high risk of sarcopenia. Therefore, higher scores mean a worse outcome.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months

  14. Body composition - Fat mass and Fat-Free mass.

    Body fat measured with bioelectrical impedance analysis.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months.

  15. Objective physical activity levels (minutes and intensities)

    Physical activity levels registered with triaxial accelerometers that they will wear during 7 days.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months

  16. Walking steps.

    Number of walking steps measured with Global Positioning System.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months.

  17. Walking distance.

    Total walking distance, in meters, measured with Global Positioning System.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months

  18. Walking speed.

    Walking speed, in meters per second, measured with Global Positioning System.

    Time frame: T0 = pre-intervention, T1 = 3 months, and T4 = 12 months.

  19. Physical activity levels

    Physical activity levels measures with Physical Activity Scale for the Elderly (PASE). It uses frequency, duration, and intensity level of activity over the previous week to assign a score, ranging from 0 to 793, with higher scores indicating greater physical activity.

    Time frame: T0 = pre-intervention, T1 = 3 months, T2 = 6 months, T3 = 9 months, and T4 = 12 months.

07

Study locations

1 site
  • EXERGNEUD Research Group
    Zaragoza, 50009, Spain
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for Dec 2026, 39 months after the start.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 39 months is above that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2024
First posted
Aug 16, 2024
StartActual
Sep 1, 2023
Primary completionEst.
Dec 20, 2026
CompletionEst.
Aug 31, 2027
Last update
May 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06556537
Responsible party
Ángel Matute-Llorente (Principal Investigator, Universidad de Zaragoza) — Principal investigator
First posted
Aug 16, 2024
Start date
Sep 1, 2023
Primary completion
Dec 20, 2026 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
May 18, 2026

Study contacts

Angel Matute-Llorente, PhD
principal investigator · University of Zaragoza - EXERGENUD Research Group

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion